Tepezza Hearing Loss & Tinnitus Lawsuit 2026: Who Qualifies, Settlements & Process
A clear 2026 guide to the Tepezza (teprotumumab) hearing loss and tinnitus lawsuit for U.S. plaintiffs. Learn the failure-to-warn theory against Horizon Therapeutics (now Amgen), MDL status, eligibility based on infusions and audiograms, proof elements, settlement tiers, contingency fees, and the statute of limitations.
Tepezza teprotumumab hearing loss lawsuit
